INTERNATIONAL PATENT: PFIZER INC. FILES APPLICATION FOR "EXTENDED RELEASE FORMULATIONS COMPRISING SUBSTITUTED INDAZOLE PROPIONIC ACID DERIVATIVE COMPOUNDS AND USES THEREOF"

GENEVA, April 13 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2025/059901) for "EXTENDED RELEASE FORMULATIONS COMPRISING SUBSTITUTED INDAZOLE PROPIONIC ACID DERIVATIVE COMPOUNDS AND USES THEREOF" on Oct 01, 2025. With publication no. WO/2026/074467, the details related to the patent application was published on Apr 09, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BERCHIELLI, Alfred (c/o Pfizer Inc.445 Eastern Point Road, Building 98Groton, Connecticut 06340), KOPINA, Brett John (c/o Pfizer Inc.445 Eastern Point Road, Building 98G...